Cardiff Lexington Corp financial data

Symbol
CDIX on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
3753 Howard Hughes Parkway, Suite 200, Las Vegas, Nevada
State of incorporation
Florida
Fiscal year end
December 31
Former names
CARDIFF INTERNATIONAL INC (to 1/26/2018)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99 % +37.9%
Debt-to-equity 2.66K %
Return On Equity 552 % +1.7%
Return On Assets 14.2 %
Operating Margin 39.4 % +5.03%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.66M shares -99%
Common Stock, Shares, Outstanding 10.8M shares -98.8%
Entity Public Float 869K USD
Common Stock, Value, Issued 10.8K USD -98.8%
Weighted Average Number of Shares Outstanding, Basic 3.82M shares +32739%
Weighted Average Number of Shares Outstanding, Diluted 3.82M shares +32739%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 11.8M USD +12.4%
Cost of Revenue 3.55M USD -8.91%
Operating Income (Loss) 4.66M USD +18.1%
Nonoperating Income (Expense) -1.74M USD +69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.91M USD -682%
Net Income (Loss) Attributable to Parent 2.76M USD -1670%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 14.6M USD +96.7%
Assets, Current 15.9M USD +104%
Property, Plant and Equipment, Net 31.3K USD -38.4%
Operating Lease, Right-of-Use Asset 416K USD +120%
Goodwill 5.67M USD 0%
Assets 22.6M USD +58.3%
Accounts Payable, Current 632K USD +28.4%
Liabilities, Current 15M USD +42.2%
Operating Lease, Liability, Noncurrent 214K USD +286%
Liabilities 15.4M USD +42.9%
Retained Earnings (Accumulated Deficit) -69.1M USD +2.93%
Stockholders' Equity Attributable to Parent 1.21M USD
Liabilities and Equity 22.6M USD +58.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.72M USD -49.6%
Net Cash Provided by (Used in) Financing Activities 2.37M USD +200%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 300M shares -96%
Common Stock, Shares, Issued 10.8M shares -98.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.25M USD +266%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD +3227%
Deferred Tax Assets, Valuation Allowance 5.29M USD -11.7%
Deferred Tax Assets, Gross 5.29M USD -11.7%
Depreciation 19.5K USD +15.1%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 410K USD +109%
Property, Plant and Equipment, Gross 137K USD -10.3%
Operating Lease, Liability, Current 196K USD +39.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 60.9K USD +9.84%
Lessee, Operating Lease, Liability, to be Paid, Year One 153K USD +8.75%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.3K USD +40%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.55K USD -71%
Additional Paid in Capital 13.8M USD
Depreciation, Depletion and Amortization 3.37K USD -27.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 195K USD